Stocks & Options
Trading Strategies
Institutional Ownership
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
BIONEXUS GENE LAB CORP Reports FY 2025 Financial Results
2026-04-14
SEC Filing 10-K
(0001477932-26-002218)
Please check the link below for details.
Ticker mentioned:
BGLC
Source:
Original SEC Document β